Nona Biosciences (HKG: 2142), a wholly-owned subsidiary of HBM Holdings Ltd, has announced a partnership with US-based animal health company Invetx, Inc. Under the agreement, Invetx will utilize Nona’s HCAb Harbour Mice platform to develop next-generation biological therapies for animal health. Financial details of the partnership were not disclosed.
Significance of the Partnership
This collaboration represents a significant milestone for Nona Biosciences as it expands into the animal health sector. The partnership further validates the flexibility and versatility of the HCAb Harbour Mice technology, which has already demonstrated its potential in various therapeutic applications. By leveraging this platform, Invetx aims to advance the development of innovative biological therapies for animal health, addressing significant unmet needs in the veterinary field.
Future Outlook
The partnership with Invetx underscores Nona Biosciences’ commitment to extending the reach of its HCAb Harbour Mice platform beyond human therapeutics. This strategic move is expected to drive innovation in the animal health sector, potentially leading to the development of novel treatments that improve the health and well-being of animals.-Fineline Info & Tech
